XOMA Royalty Corporation (XOMAP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Last updated: Nov 06, 2026 at 4:00 PM ET
XOMA Royalty Corporation (XOMAP) Financials: Revenue, Profit and Cash Flow
XOMA Royalty reported revenue of $52.15M for the fiscal year ended Dec 31, 2025, up 83.1% from the year before. That year, net income was $31.71M with a net margin of 60.8%, operating cash flow was $2.87M and free cash flow was -$17.85M. The quarter ended Mar 31, 2026 had revenue of $12.32M and net income of $4.46M.
Revenue and Margins
The operating margin was 21.8% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $5.56M, a compound annual rate of 28.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $52.15M | +83.1% | 94.3% | 21.8% | 60.8% |
| Dec 2024 | $28.49M | +498.7% | 99.3% | -140.3% | -48.5% |
| Dec 2023 | $4.76M | -21.1% | 97.0% | -879.5% | -858.2% |
| Dec 2022 | $6.03M | -84.2% | 95.5% | -288.9% | -283.8% |
| Dec 2021 | $38.16M | +29.9% | 99.6% | 45.9% | 41.4% |
| Dec 2020 | $29.39M | +60.0% | 99.4% | 42.3% | 45.3% |
| Dec 2019 | $18.37M | +246.7% | 93.2% | -21.1% | -10.8% |
| Dec 2018 | $5.30M | -89.9% | 68.3% | -318.1% | -251.8% |
| Dec 2017 | $52.69M | +847.0% | 85.1% | 32.3% | 27.7% |
| Dec 2016 | $5.56M | N/A | 74.8% | -1106.4% | -962.1% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Mar 2026, net income rose 88.2% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52.15M | $28.49M | $4.76M | $6.03M | $38.16M | $29.39M | $18.37M | $5.30M | $52.69M | $5.56M |
| Cost of revenue | $2.96M | $206.00K | $143.00K | $274.00K | $171.00K | $170.00K | $1.25M | $1.68M | $7.88M | $1.40M |
| Gross profit | $49.19M | $28.28M | $4.62M | $5.75M | $37.99M | $29.21M | $17.12M | $3.62M | $44.81M | $4.16M |
| Research and development | $1.71M | $2.88M | $143.00K | $153.00K | $171.00K | $170.00K | $1.25M | $1.68M | $7.88M | $44.23M |
| Operating income | $11.38M | -$39.98M | -$41.85M | -$17.41M | $17.53M | $12.42M | -$3.88M | -$16.86M | $17.03M | -$61.56M |
| Net income | $31.71M | -$13.82M | -$40.83M | -$17.10M | $15.80M | $13.30M | -$1.98M | -$13.34M | $14.60M | -$53.53M |
| EBITDA | $47.82M | -$5.42M | -$22.56M | -$16.84M | N/A | $13.81M | $1.85M | -$12.49M | $20.78M | -$48.81M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.32M | $1.43M | $532.00K | $13.13M | $15.91M | $8.71M | $7.20M | $11.09M | $1.49M | $1.83M | $830.00K | $1.66M |
| Gross profit | $11.42M | $1.43M | $532.00K | $12.47M | $14.62M | $8.51M | $6.38M | $9.93M | $1.49M | $1.81M | $805.00K | $1.62M |
| Operating income | -$480.00K | $2.18M | -$1.33M | $4.60M | $5.93M | -$16.25M | -$15.64M | -$10.08M | -$7.00M | -$19.93M | -$5.79M | -$5.96M |
| Net income | $4.46M | $6.10M | $14.05M | $9.19M | $2.37M | -$3.97M | -$17.24M | $15.98M | -$8.60M | -$20.11M | -$5.51M | -$5.40M |
Balance Sheet
As of Dec 2025, total debt of $111.44M exceeded cash and equivalents by $28.53M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $272.70M | $221.28M | $234.30M | $140.38M | $166.56M | $125.28M | $95.72M | $63.78M | $44.94M | $28.68M |
| Current assets | $117.26M | $125.60M | $169.31M | $61.25M | $96.97M | $88.06M | $59.97M | $47.63M | $44.20M | $27.16M |
| Cash and equivalents | $82.91M | $101.65M | $153.29M | $57.83M | $93.33M | $84.22M | $56.69M | $45.78M | $43.47M | $25.74M |
| Total liabilities | $168.74M | $139.36M | $145.58M | $16.37M | $24.69M | $38.86M | $51.74M | $45.00M | $39.15M | $75.89M |
| Short-term debt | $14.99M | $11.84M | $5.60M | $34.00K | $195.00K | $8.27M | $5.35M | $789.00K | $3.35M | $17.86M |
| Long-term debt | $96.45M | $106.88M | $118.52M | N/A | N/A | $12.76M | $27.09M | $21.69M | $14.57M | N/A |
| Shareholder equity | $103.96M | $81.92M | $88.72M | $124.01M | $141.88M | $86.42M | $43.99M | $18.79M | $5.79M | -$47.21M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $271.86M | $272.70M | $263.15M | $223.46M | $212.75M | $221.28M | $223.34M | $243.28M | $219.42M | $234.30M | $124.09M | $125.66M |
| Total liabilities | $158.96M | $168.74M | $155.19M | $131.00M | $128.12M | $139.36M | $138.53M | $143.29M | $137.08M | $145.58M | $18.13M | $15.54M |
| Cash and equivalents | $94.46M | $82.91M | $90.48M | $75.06M | $90.27M | $101.65M | $142.05M | $143.90M | $136.38M | $153.29M | $33.47M | $31.45M |
| Shareholder equity | $112.89M | $103.96M | $107.96M | $92.45M | $84.63M | $81.92M | $84.81M | $99.99M | $82.34M | $88.72M | $105.96M | $110.12M |
Cash Flow
In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.87M | -$13.75M | -$18.16M | -$12.88M | $22.68M | $10.09M | -$285.00K | -$12.64M | $2.69M | -$33.69M |
| Capital expenditures | $20.73M | $20.00K | $17.00K | $23.25M | $26.50M | $1.21M | $19.30M | $15.01M | $8.00K | $59.00K |
| Free cash flow | -$17.85M | -$13.77M | -$18.18M | -$36.13M | -$3.82M | $8.88M | -$19.59M | -$27.65M | $2.68M | -$33.75M |
| Dividends paid | $5.47M | $5.47M | $5.47M | $5.47M | $3.50M | $2.40M | $276.00K | $3.50M | N/A | N/A |
| Investing cash flow | $50.89M | -$28.26M | -$711.00K | -$20.22M | -$26.50M | -$209.00K | -$19.30M | -$15.01M | $1.61M | $612.00K |
| Financing cash flow | -$26.46M | -$11.13M | $120.59M | -$4.45M | $12.84M | $19.79M | $30.49M | $29.94M | $13.26M | -$6.94M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.04M | -$5.50M | -$296.00K | $6.39M | $2.20M | -$2.90M | -$8.70M | $2.73M | -$5.53M | -$3.93M | -$2.10M | -$7.21M |
| Capital expenditures | $0 | $0 | $111.00K | $0 | $0 | $3.00K | $0 | $0 | $17.00K | $17.00K | $0 | $0 |
| Free cash flow | $6.04M | -$5.50M | -$407.00K | $6.39M | $2.20M | -$2.91M | -$8.70M | $2.73M | -$5.54M | -$3.94M | -$2.10M | -$7.21M |
Frequently Asked Questions About XOMAP
What is XOMA Royalty's annual revenue?
XOMA Royalty reported revenue of $52.15M for the fiscal year ended Dec 31, 2025.
How fast is XOMA Royalty's revenue growing?
Revenue was up 83.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 105.3%.
Is XOMA Royalty profitable?
Yes. XOMA Royalty reported net income of $31.71M for the fiscal year ended Dec 31, 2025, with a net margin of 60.8%.
How much free cash flow does XOMAP generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $2.87M minus capital expenditures of $20.73M produced free cash flow of -$17.85M.
How much debt does XOMA Royalty have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $96.45M, short-term debt of $14.99M and cash and equivalents of $82.91M.
XOMAP pages: Overview, Dividends, Financials